$OCGN
Ocugen, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$1.05
▲+1.94%+$0.020
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateOcugen, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is OCGN up today? It is at $1.05 (+1.94%), and our scanner flagged it 165 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment OCGN spikes, and full due diligence on OCGN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $OCGN 165 times in the last 30 days. Create a free account to track $OCGN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on OCGN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for OCGN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing4Insider trade (Form 4)Sep 12, 2026 · 9 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Musunuri Shankar Officer | Sold (automatic/other) | -469K 0.1% of company | sold 9.5% | 4.49M | $525K at $1.12 | Sep 9, 26 |
Musunuri Shankar Officer | Sold (automatic/other) | -57K 0.02% of company | sold 5.0% | 1.09M | $64K at $1.12 | Sep 9, 26 |
Johnson-Greene Treerita Essalima Officer | Bought (open market) | +21K | added 4.2% | 521K | $26K at $1.23 | Jun 15, 26 |
Zhang Junge Director | Other | 194K 0.06% of company | added 17% | 1.36M | $89K at $0.460 | Apr 1, 26 |
Ramachandran Ramesh Officer | Acquired (grant/award) | +207K 0.06% of company | added 100% | 209K | n/a | Jan 2, 26 |
Musunuri Shankar Officer | Acquired (grant/award) | +3.12M 0.9% of company | added 100% | 4.96M | n/a | Jan 2, 26 |
Musunuri Shankar Officer | Sold (automatic/other) | -177K 0.05% of company | sold 8.8% | 1.83M | $158K at $0.890 | Jan 3, 25 |
Upadhyay Arun Officer | Sold (automatic/other) | -42K 0.01% of company | sold 12% | 306K | $37K at $0.890 | Jan 3, 25 |
Fernandes Prabhavathi Director | Bought (open market) | +10K | n/a | 10K | $9K at $0.910 | Nov 26, 24 |
Castillo Kirsten Director | Bought (open market) | +25K | added 50% | 75K | $23K at $0.910 | Nov 22, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on OCGN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for OCGN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
OCGN last traded at $1.05, up 1.94% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Ocugen, Inc. Common Stock (OCGN) is next expected to report earnings on Wednesday, November 4, 2026, about 45 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The OCGN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged OCGN 165 times in the last 30 days.
OCGN (Ocugen, Inc. Common Stock) trades on XNAS, with a market cap of about $359M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge OCGN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$OCGN discussion
Sign in to ask a question or join the discussion.